Johnson & Johnson files for emergency approval of single-dose COVID vaccine

Pharmaceutical giant Johnson & Johnson on Thursday filed for emergency authorization of its one-dose COVID-19 vaccine. The company’s inoculation is 66 percent effective against moderate to severe cases of the deadly global pandemic, but it only requires a single dose and offers strong protection against hospitalization and death from the bug, Politico reported. The J&J…
Read More